Denali Therapeutics Inc.
METHODS FOR TREATING AND MONITORING PROGRANULIN-ASSOCIATED DISORDERS

Abstract:

The present disclosure provides methods and materials for screening a compound or monitoring a subjects response to a compound or dosing regimen for treating a PGRN-associated disorder. Methods and materials for identifying and treating a subject having a PGRN-associated disorder are also provided.